Company intelligence / Profile preview

MillenHeureux

Cambridge, Massachusetts, United Statesgutenberg.org ↗

Ownership: Private
Development stage: Other

Overview

Takeda Oncology—formerly Millennium Pharmaceuticals—is a leading biopharmaceutical subsidiary of Takeda Pharmaceutical. It was renowned for pioneering genomics-driven drug discovery and developing the proteasome inhibitor bortezomib (Velcade) for multiple myeloma. Since its $8.8B acquisition by Takeda in 2008, it has operated as the oncology-focused arm within one of the world’s largest pharmaceutical companies. Its clinical results include FDA approval and global commercialization of Velcade and participation in a broad portfolio spanning oncology and inflammation therapeutics.

Therapeutic areas: OncologyOther
Modalities: Small moleculeMonoclonal antibodyBiologicAntibody-drug conjugate
Industry: Pharma

Partnerships

Historically partnered with Schering-Plough on Integrilinnumerous alliances pre-acquisition (>20 strategic partnerships)now participates in global partnerships through parent

Beyond the preview

Go deeper on MillenHeureux.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MillenHeureux.

Explore the full profile